BioCentury
ARTICLE | Clinical News

Dryhaler inhaler using a dry powder formulation of albuterol: Interim results from DURA's dose-selection trial have been reviewed by the company and judged as f

May 1, 1995 7:00 AM UTC

Dura Pharmaceuticals Inc. (DURA), San Diego Product: Dryhaler inhaler using a dry powder formulation of albuterol Indication: Asthma Status: Interim results from DURA's dose-selection trial have been ...